National insurer targets outpatient imaging centers
The American College of Radiology has seen regional victories related to its campaign to have insurers enact methods to guarantee quality and appropriateness. In January, the UnitedHealth Group, which serves 70 million individuals nationwide, announced it wants outpatient imaging facilities in all 50 states to be accredited by next March.
The American College of Radiology has seen regional victories related to its campaign to have insurers enact methods to guarantee quality and appropriateness. In January, the UnitedHealth Group, which serves 70 million individuals nationwide, announced it wants outpatient imaging facilities in all 50 states to be accredited by next March.
UnitedHealth's accreditation program targets freestanding outpatient facilities and physician offices that perform CT and CT angiography, MRI and MR angiography, nuclear medicine, nuclear cardiology, PET, and echocardiography services.
"While it's a move in the right direction, payers should also ensure that patients receive the appropriate exam and that the exam is not the result of inappropriate self-referral," said Dr. Alan Kaye, a member of the ACR steering committee.
FDA Clears Enhanced MRI-Guided Laser Ablation System
June 5th 2025An alternative to an open neurosurgical approach, the Visualase V2 MRI-Guided Laser Ablation System reportedly utilizes laser interstitial thermal therapy (LITT) for targeted soft tissue ablation in patients with brain tumors and focal epilepsy.
Can Abbreviated MRI Have an Impact in Differentiating Intraductal Papilloma and Ductal Secretion?
June 3rd 2025For patients with inconclusive ultrasound results, abbreviated breast MRI offers comparable detection of intraductal papilloma as a full breast MRI protocol at significantly reduced times for scan acquisition and interpretation, according to a new study.
FDA Issues Expanded Pediatric Approval of MRI Contrast Agent for Lung Ventilation Assessment
June 2nd 2025Previously approved for MRI lung ventilation evaluation in adults and children 12 and older, the hyperpolarized contrast agent Xenoview can now be utilized for pediatric patients six years and older.
